Martinek, M.; Crijns, H.J.G.M.; Essers, B.A.B.; Wiesinger, R.; Pruckner, G.
Healthcare Utilization and Outcomes in Atrial Fibrillation Patients Treated by Drug Therapy versus a Catheter Ablation Strategy—A Middle European Propensity Score Matched Cohort Study. J. Cardiovasc. Dev. Dis. 2022, 9, 451.
https://doi.org/10.3390/jcdd9120451
AMA Style
Martinek M, Crijns HJGM, Essers BAB, Wiesinger R, Pruckner G.
Healthcare Utilization and Outcomes in Atrial Fibrillation Patients Treated by Drug Therapy versus a Catheter Ablation Strategy—A Middle European Propensity Score Matched Cohort Study. Journal of Cardiovascular Development and Disease. 2022; 9(12):451.
https://doi.org/10.3390/jcdd9120451
Chicago/Turabian Style
Martinek, Martin, Harry J. G. M. Crijns, Barbara A. B. Essers, Rene Wiesinger, and Gerald Pruckner.
2022. "Healthcare Utilization and Outcomes in Atrial Fibrillation Patients Treated by Drug Therapy versus a Catheter Ablation Strategy—A Middle European Propensity Score Matched Cohort Study" Journal of Cardiovascular Development and Disease 9, no. 12: 451.
https://doi.org/10.3390/jcdd9120451
APA Style
Martinek, M., Crijns, H. J. G. M., Essers, B. A. B., Wiesinger, R., & Pruckner, G.
(2022). Healthcare Utilization and Outcomes in Atrial Fibrillation Patients Treated by Drug Therapy versus a Catheter Ablation Strategy—A Middle European Propensity Score Matched Cohort Study. Journal of Cardiovascular Development and Disease, 9(12), 451.
https://doi.org/10.3390/jcdd9120451